CN Patent

CN102048717B — 一种稳定的雷沙吉兰组合物

Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2014-02-19 · 12y expired

What this patent protects

本发明涉及一种稳定的雷沙吉兰组合物，含有有效量的雷沙吉兰或其药物上可接受的盐和作为稳定剂的抗氧剂，其制剂形式为透皮及粘膜用药制剂，如可以为贴片、凝胶、软膏、乳膏、巴布剂、膜剂、喷雾剂、溶液剂等药剂学上常用的经皮及粘膜给药剂型。该组合物用于治疗或预防精神系统疾病。

USPTO Abstract

本发明涉及一种稳定的雷沙吉兰组合物，含有有效量的雷沙吉兰或其药物上可接受的盐和作为稳定剂的抗氧剂，其制剂形式为透皮及粘膜用药制剂，如可以为贴片、凝胶、软膏、乳膏、巴布剂、膜剂、喷雾剂、溶液剂等药剂学上常用的经皮及粘膜给药剂型。该组合物用于治疗或预防精神系统疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN102048717B
Jurisdiction
CN
Classification
—
Expires
2014-02-19
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Pharmaceutical Research Institute Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.